Serum testosterone and prostate cancer in men with germline BRCA1/2 pathogenic variants by Alexander Dias, Mark N. Brook, Elizabeth K. Bancroft, Elizabeth C. Page, Anthony Chamberlain, Sibel Saya, Jan Amin, Christos Mikropoulos, Natalie Taylor, Kathryn Myhill, Sarah Thomas, Edward Saunders, Tokhir Dadaev, Daniel Leongamornlert, Thomas Dyrsø Jensen, D. Gareth Evans, Cezary Cybulski, Annelie Liljegren, Soo H. Teo, Lucy Side, The IMPACT study collaborators and Steering Committee, Zsofia Kote‐Jarai, Rosalind A. Eeles

Get full text